Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELIXINOL WELLNESS LIMITED Call Transcript 2019

Feb 20, 2019

64891_rns_2019-02-20_76325018-9fc0-4e68-a9be-ef7a889e2031.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [131 x 91] intentionally omitted <==

ASX Announcement 21 February 2019

Elixinol Global FY2018 results conference call

Elixinol Global Limited (EXL or the Company) (ASX:EXL; OTCQX:ELLXF), a global company operating in the industrial hemp, dietary supplements and emerging medicinal cannabis sectors, is pleased to invite investors to participate in the FY2018 results presentation by Chief Executive Officer, Paul Benhaim and Chief Financial Officer, Ron Dufficy, on Tuesday 26 February at 11:00 am (AEST / Sydney time).

During the call, Paul Benhaim and Ron Dufficy will present the Company’s FY2018 results, followed by a Q&A session.

Date and time Tuesday 26 February at 11:00 am am (AEST / Sydney time)

Dial-in details Australia 1800 558 698 United Kingdom 0800 051 8245 United States 1 877 642 9125 Canada 1855 8811 339 Hong Kong 800 966 806 Singapore 800 101 2785 Conference ID 788412

Investor relations and media please contact:

Australia
Glen Zurcher
Account Director, IR Department
[email protected]
+61 420 249 299
United States of America
Cody Slach
Managing Director, Liolios Group Inc
[email protected]
+1 949 574 3860

About Elixinol Global

Elixinol Global Limited (ASX:EXL; OTCQX:ELLXF) through its businesses has a global presence in the cannabis industry including hemp-derived CBD dietary supplements, hemp

ELIXINOL GLOBAL LIMITED ACN 621 479 794 | PO BOX 20547, WORLD SQUARE NSW 2002 AUSTRALIA [email protected] | WWW.ELIXINOLGLOBAL.COM | +61 2 4044 4585

==> picture [131 x 91] intentionally omitted <==

food and wellness products, as well as cultivation and manufacture of medicinal cannabis products. EXL’s businesses include:

  • Elixinol LLC (“Elixinol”) , founded in 2014, is a manufacturer and global distributor of hemp dietary supplement and skincare products, with operations based out of Colorado, USA.

  • Hemp Foods Australia , founded in 1999, is a leading hemp food wholesaler, retailer, manufacturer and exporter of bulk and branded raw materials, and finished products.

  • Nunyara Pharma Pty Ltd (“Nunyara”) , formerly known as Elixinol Australia, was founded in 2014 to participate in the emerging Australian medicinal cannabis market and submitted licence applications for cultivation and manufacture to the Office of Drug Control in early 2018. These applications are currently pending approval.

See more at www.elixinolglobal.com

ELIXINOL GLOBAL LIMITED ACN 621 479 794 | PO BOX 20547, WORLD SQUARE NSW 2002 AUSTRALIA [email protected] | WWW.ELIXINOLGLOBAL.COM | +61 2 4044 4585